Carmel Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Sell |
3,582
-145
| -4% | -$26.9K | 0.23% | 78 |
|
|
2025
Q1 | $781K | Sell |
3,727
-19
| -0.5% | -$3.98K | 0.31% | 67 |
|
|
2024
Q4 | $666K | Sell |
3,746
-306
| -8% | -$54.4K | 0.27% | 69 |
|
|
2024
Q3 | $800K | Sell |
4,052
-54
| -1% | -$10.7K | 0.31% | 66 |
|
|
2024
Q2 | $704K | Buy |
4,106
+45
| +1% | +$7.72K | 0.3% | 66 |
|
|
2024
Q1 | $740K | Hold |
4,061
| – | – | 0.31% | 67 |
|
|
2023
Q4 | $629K | Sell |
4,061
-589
| -13% | -$91.3K | 0.32% | 66 |
|
|
2023
Q3 | $693K | Buy |
4,650
+491
| +12% | +$73.2K | 0.31% | 68 |
|
|
2023
Q2 | $560K | Buy |
4,159
+22
| +0.5% | +$2.96K | 0.29% | 66 |
|
|
2023
Q1 | $659K | Sell |
4,137
-451
| -10% | -$71.9K | 0.39% | 60 |
|
|
2022
Q4 | $741K | Buy |
4,588
+775
| +20% | +$125K | 0.51% | 48 |
|
|
2022
Q3 | $512K | Buy |
3,813
+117
| +3% | +$15.7K | 0.49% | 56 |
|
|
2022
Q2 | $566K | Buy |
3,696
+342
| +10% | +$52.4K | 0.53% | 59 |
|
|
2022
Q1 | $544K | Buy |
3,354
+302
| +10% | +$49K | 0.45% | 60 |
|
|
2021
Q4 | $413K | Buy |
+3,052
| New | +$413K | 0.31% | 67 |
|